ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/10/26 | 1,777 | 1,923 | 1,770 | 1,868 | +66 | +3.7% | 3,780,600 |
2023/10/25 | 1,820 | 1,848 | 1,760 | 1,802 | +6 | +0.3% | 2,372,700 |
2023/10/24 | 1,952 | 2,012 | 1,661 | 1,796 | -184 | -9.3% | 6,879,800 |
2023/10/23 | 2,100 | 2,119 | 1,866 | 1,980 | +91 | +4.8% | 7,166,800 |
2023/10/20 | 1,866 | 1,920 | 1,835 | 1,889 | -17 | -0.9% | 1,561,400 |
2023/10/19 | 1,920 | 1,942 | 1,876 | 1,906 | -50 | -2.6% | 1,765,500 |
2023/10/18 | 1,961 | 2,004 | 1,927 | 1,956 | -6 | -0.3% | 2,058,200 |
2023/10/17 | 1,958 | 1,976 | 1,893 | 1,962 | +111 | +6% | 2,582,400 |
2023/10/16 | 2,061 | 2,064 | 1,838 | 1,851 | -278 | -13.1% | 4,440,700 |
2023/10/13 | 2,164 | 2,181 | 2,113 | 2,129 | -34 | -1.6% | 2,030,500 |
2023/10/12 | 2,236 | 2,236 | 2,151 | 2,163 | -47 | -2.1% | 1,987,000 |
2023/10/11 | 2,224 | 2,298 | 2,208 | 2,210 | +7 | +0.3% | 3,156,900 |
2023/10/10 | 2,098 | 2,229 | 2,075 | 2,203 | +133 | +6.4% | 3,088,300 |
2023/10/06 | 2,033 | 2,079 | 1,978 | 2,070 | +52 | +2.6% | 2,286,100 |
2023/10/05 | 2,025 | 2,043 | 1,973 | 2,018 | +1 | ±0% | 2,292,900 |
2023/10/04 | 2,019 | 2,063 | 1,992 | 2,017 | -44 | -2.1% | 2,798,300 |
2023/10/03 | 2,011 | 2,072 | 1,947 | 2,061 | +37 | +1.8% | 3,004,100 |
2023/10/02 | 2,049 | 2,092 | 2,021 | 2,024 | -14 | -0.7% | 3,157,600 |
2023/09/29 | 2,009 | 2,073 | 2,009 | 2,038 | +46 | +2.3% | 2,921,000 |
2023/09/28 | 1,999 | 2,009 | 1,946 | 1,992 | +2 | +0.1% | 1,977,100 |
2023/09/27 | 1,934 | 2,000 | 1,922 | 1,990 | +40 | +2.1% | 2,340,900 |
2023/09/26 | 1,989 | 2,007 | 1,911 | 1,950 | -39 | -2% | 2,583,800 |
2023/09/25 | 1,938 | 2,022 | 1,926 | 1,989 | +43 | +2.2% | 2,905,500 |
2023/09/22 | 1,882 | 1,979 | 1,876 | 1,946 | +37 | +1.9% | 3,857,200 |
2023/09/21 | 2,150 | 2,160 | 1,890 | 1,909 | -267 | -12.3% | 6,169,900 |
2023/09/20 | 2,140 | 2,264 | 2,135 | 2,176 | +44 | +2.1% | 3,998,700 |
2023/09/19 | 2,148 | 2,165 | 2,076 | 2,132 | -27 | -1.3% | 2,590,500 |
2023/09/15 | 2,203 | 2,252 | 2,116 | 2,159 | -34 | -1.6% | 3,157,000 |
2023/09/14 | 2,135 | 2,208 | 2,097 | 2,193 | +68 | +3.2% | 3,448,100 |
2023/09/13 | 2,198 | 2,242 | 2,125 | 2,125 | -79 | -3.6% | 4,496,400 |
2023/09/12 | 2,255 | 2,358 | 2,201 | 2,204 | -38 | -1.7% | 9,358,800 |
2023/09/11 | 2,140 | 2,268 | 2,110 | 2,242 | +102 | +4.8% | 5,055,400 |
2023/09/08 | 2,100 | 2,179 | 2,091 | 2,140 | +31 | +1.5% | 3,909,700 |
2023/09/07 | 2,186 | 2,206 | 2,071 | 2,109 | -127 | -5.7% | 6,223,600 |
2023/09/06 | 2,246 | 2,285 | 2,195 | 2,236 | -10 | -0.4% | 4,963,100 |
2023/09/05 | 2,189 | 2,318 | 2,189 | 2,246 | +60 | +2.7% | 8,793,900 |
2023/09/04 | 2,111 | 2,220 | 2,085 | 2,186 | +54 | +2.5% | 8,708,100 |
2023/09/01 | 2,200 | 2,220 | 2,012 | 2,132 | -8 | -0.4% | 12,809,100 |
2023/08/31 | 2,354 | 2,382 | 2,111 | 2,140 | -258 | -10.8% | 16,190,300 |
2023/08/30 | 2,259 | 2,408 | 2,235 | 2,398 | +102 | +4.4% | 11,150,300 |
2023/08/29 | 2,288 | 2,346 | 2,203 | 2,296 | +31 | +1.4% | 11,930,300 |
2023/08/28 | 2,095 | 2,295 | 2,090 | 2,265 | +170 | +8.1% | 12,027,500 |
2023/08/25 | 2,039 | 2,128 | 1,957 | 2,095 | +25 | +1.2% | 9,971,900 |
2023/08/24 | 2,150 | 2,271 | 1,897 | 2,070 | -99 | -4.6% | 23,692,000 |
2023/08/23 | 2,070 | 2,193 | 2,016 | 2,169 | +83 | +4% | 10,579,600 |
2023/08/22 | 1,970 | 2,096 | 1,941 | 2,086 | +116 | +5.9% | 12,291,300 |
2023/08/21 | 1,812 | 2,041 | 1,812 | 1,970 | +165 | +9.1% | 11,067,800 |
2023/08/18 | 1,751 | 1,805 | 1,666 | 1,805 | +4 | +0.2% | 5,448,900 |
2023/08/17 | 1,711 | 1,822 | 1,688 | 1,801 | +88 | +5.1% | 5,403,000 |
2023/08/16 | 1,590 | 1,748 | 1,570 | 1,713 | +134 | +8.5% | 6,153,900 |
351~
400
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 79,600円 | +22.8% | - | 0.00% | 65.03倍 | 1.04倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム